Jeff Ajer
2016
In 2016, Jeff Ajer earned a total compensation of $4.7M as Executive Vice President, Chief Commercial Officer at BioMarin Pharmaceutical, a 26% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $357,750 |
|---|---|
| Option Awards | $1,541,900 |
| Salary | $490,385 |
| Stock Awards | $2,316,017 |
| Other | $16,361 |
| Total | $4,722,413 |
Ajer received $2.3M in stock awards, accounting for 49% of the total pay in 2016.
Ajer also received $357.8K in non-equity incentive plan, $1.5M in option awards, $490.4K in salary and $16.4K in other compensation.
Rankings
In 2016, Jeff Ajer's compensation ranked 1,761st out of 14,075 executives tracked by ExecPay. In other words, Ajer earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,761 out of 14,075 | 88th |
Division Manufacturing | 601 out of 5,488 | 89th |
Major group Chemicals And Allied Products | 168 out of 1,900 | 91st |
Industry group Drugs | 117 out of 1,543 | 92nd |
Industry Pharmaceutical Preparations | 93 out of 1,173 | 92nd |
Source: SEC filing on April 25, 2017.
Ajer's colleagues
We found four more compensation records of executives who worked with Jeff Ajer at BioMarin Pharmaceutical in 2016.
2016
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2016
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2016
Daniel Spiegelman
BioMarin Pharmaceutical
Chief Financial Officer
2016
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
News
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2021 pay rises 1% to $18M
April 12, 2022
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2020 pay slips 2% to $18M
April 13, 2021
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2019 pay rises 18% to $18M
April 14, 2020
BioMarin Pharmaceutical CEO Jean-Jacques Bienaim's 2018 pay slips 2% to $16M
April 23, 2019